Cure My Disease

Don't miss your cure!

 Log in / Sign up

First patients receive experimental cancer drug targeting tough tumors

NCT ID NCT06641908

Recruiting now Disease control Sponsor: EMD Serono Research & Development Institute, Inc. Source: ClinicalTrials.gov ↗

Summary

This is the first time researchers are testing the experimental drug M3554 in people. The study aims to find safe doses and check early signs of effectiveness in adults with advanced soft tissue sarcoma or glioblastoma brain cancer that has worsened after standard treatments. Participants will receive the drug to see how their bodies handle it and if it helps control their cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Antoine Lacassagne - Service d'Hématologie Oncologie

    RECRUITING

    Nice, France

  • Centre Leon Berard - Service d'Oncologie Medicale

    RECRUITING

    Lyon, France

  • Centre Oscar Lambret - cancerologie generale

    RECRUITING

    Lille, France

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Institut Bergonié - Service d'Oncologie Médicale

    RECRUITING

    Bordeaux, France

  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc

    WITHDRAWN

    New York, New York, 10022, United States

  • National Cancer Center Hospital

    RECRUITING

    Chūōku, Japan

  • Royal Marsden Hospital-Sutton - Dept of Oncology (Surrey)

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • Universitaetsspital Zuerich - Klinik fuer Neurologie

    RECRUITING

    Zurich, 8091, Switzerland

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR